SFY Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Theriva Biologics Inc - Alpha Spread

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc Logo
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR Market Closed
Market Cap: 41.8m EUR
Have any thoughts about
Theriva Biologics Inc?
Write Note

Wall Street
Price Targets

SFY Price Targets Summary
Theriva Biologics Inc

Wall Street analysts forecast SFY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SFY is 2.74 EUR with a low forecast of 0.68 EUR and a high forecast of 4.94 EUR.

Lowest
Price Target
0.68 EUR
72% Downside
Average
Price Target
2.74 EUR
13% Upside
Highest
Price Target
4.94 EUR
104% Upside
Theriva Biologics Inc Competitors:
Price Targets
DAWN
Day One Biopharmaceuticals Inc
191% Upside
4891
TMS Co Ltd
294% Upside
BIO
Biotest AG
19% Downside
ALKS
Alkermes Plc
29% Upside
COV
Covalon Technologies Ltd
154% Upside
9926
Akeso Inc
14% Downside
6955
Shandong Boan Biotechnology Co Ltd
15% Upside
BIOPOR
Bioporto A/S
53% Upside

Revenue
Forecast

Revenue Estimate
Theriva Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Theriva Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Theriva Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SFY's stock price target?
Price Target
2.74 EUR

According to Wall Street analysts, the average 1-year price target for SFY is 2.74 EUR with a low forecast of 0.68 EUR and a high forecast of 4.94 EUR.

Back to Top